Fujita H, Ogawa K, Tone H, Iguchi H, Shomura T, Murata S
Jpn J Antibiot. 1986 May;39(5):1321-36.
The following paragraphs summarize the properties of ADR, THP and ACR in terms of their pharmacokinetics. The blood level of anthracyclines shows a three-phase function of decline: alpha, beta and gamma phases. Compared with other classes of anticancer agents, the anthracyclines are characterized by an extremely short T1/2(alpha) and an extremely long T1/2(gamma). These characteristics reflect the facts that anthracyclines are rapidly transferred to the tissues and that they are retained for a long time in the body. In comparison with ADR, the T1/2(alpha) of THP is relatively short and T1/2(alpha, beta and gamma) of ACR are also short. Anthracyclines show large values for K12 and K13, transfer rate constants of the drug from the blood to the tissues, and small values for K21 and K31 transfer rate constants of the drug from the tissues to the blood. This means that these drugs are rapidly transferred to the tissues, from which they are then slowly released. The order of magnitude of K12 and K13 was THP greater than ACR greater than ADR. The order for K21 and K31 was ACR greater than THP greater than ADR. Anthracyclines are also characterized by small distribution volumes (V1) in the blood circulation, and very large distribution volumes (V2 and V3) in the tissue compartments. The order of magnitude for V2 and V3 was THP greater than ADR greater than ACR. Anthracyclines achieved high concentrations in such thoracic and abdominal organs such as lung, heart, thymus, liver, kidney, spleen and digestive tract. ADR showed the highest levels in liver and kidney, while THP and ACR showed their highest concentrations in lung and spleen. A decrease in the drug concentration in various organs is slow in the case of ADR, while rapid in the cases of THP and ACR. Most of the distributed drug is the unchanged form with ADR, whereas metabolites are common with ACR. THP is partially converted to ADR in liver. Anthracyclines were usually excreted over a long period of time at a high rate in the bile and at a low rate in the urine. Orally-administered ACR showed considerably good absorption from the digestive tract. The metabolism of anthracyclines was carried out in vivo and resulted in the formation of bioactive glycoside metabolites and inactive aglycone metabolites.(ABSTRACT TRUNCATED AT 400 WORDS)
以下段落从药代动力学方面总结了阿霉素(ADR)、吡柔比星(THP)和阿克拉霉素(ACR)的特性。蒽环类药物的血药浓度呈三相下降:α、β和γ相。与其他类抗癌药物相比,蒽环类药物的特点是T1/2(α)极短,T1/2(γ)极长。这些特性反映了蒽环类药物迅速转移至组织且在体内长时间留存的事实。与ADR相比,THP的T1/2(α)相对较短,ACR的T1/2(α、β和γ)也较短。蒽环类药物的K12和K13(药物从血液转移至组织的转运速率常数)值较大,而K21和K31(药物从组织转移至血液的转运速率常数)值较小。这意味着这些药物迅速转移至组织,然后从组织中缓慢释放。K12和K13的量级顺序为THP大于ACR大于ADR。K21和K31的顺序为ACR大于THP大于ADR。蒽环类药物的另一个特点是在血液循环中的分布容积(V1)较小,而在组织隔室中的分布容积(V2和V3)非常大。V2和V3的量级顺序为THP大于ADR大于ACR。蒽环类药物在肺、心脏、胸腺、肝脏、肾脏、脾脏和消化道等胸腹部器官中达到高浓度。ADR在肝脏和肾脏中水平最高,而THP和ACR在肺和脾脏中浓度最高。ADR在各器官中的药物浓度下降缓慢,而THP和ACR则下降迅速。分布的药物中,ADR大部分为原形,而ACR则以代谢产物为主。THP在肝脏中部分转化为ADR。蒽环类药物通常在很长一段时间内以高胆汁排泄率和低尿排泄率排泄。口服的ACR在消化道的吸收相当良好。蒽环类药物在体内进行代谢,产生生物活性糖苷代谢产物和无活性苷元代谢产物。(摘要截选至400字)